Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03079661
Other study ID # RNI2016-42
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date January 1, 2017
Est. completion date January 14, 2019

Study information

Verified date July 2020
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

All COPD patients with a diagnosis of acute exacerbation in emergency room in University Hospital of Amiens-Picardie between 01/01/2017 and 31/12/2017. The investigator will collect for each patient the home address and the work address. The duration of 1 year was chosen to take into account seasonal variations. In parallel, a daily report of the rate of ozone, particles (PM2.5 and PM10), dioxide nitrogen but also odours and pollens will be done by ATMO Picardie.


Recruitment information / eligibility

Status Terminated
Enrollment 179
Est. completion date January 14, 2019
Est. primary completion date January 14, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- All COPD patients with a diagnosis of acute exacerbation of COPD in the emergency room. The definition of COPD and acute exacerbation are the official definition of the Société de Pneumologie en Langue Française.

Exclusion Criteria:

- no exclusion criteria

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHU Amiens Picardie Amiens Picardie

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary exacerbation rate : variable to be explicated with explicative variable : ozone, particles, dioxide nitrogen, but also pollens corresponding to each patient home address for period of exacerbation exacerbation rate : variable to be explicated with explicative variable : ozone, particles, dioxide nitrogen, but also pollens corresponding to each patient home address for period of exacerbation 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT03440060 - Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD N/A
Not yet recruiting NCT03277001 - Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD N/A
Not yet recruiting NCT06143150 - Prediction of Outcome of Non Invasive Ventilation COPD Patients by Assessment of Diaphragmatic Performance
Recruiting NCT03823443 - COPD Exacerbation Blood and Urine Biomarkers Study
Not yet recruiting NCT06123780 - Pattern of Microbial Infection in AECOPD Patients and Its Sensitivity to Antibiotics
Recruiting NCT03466385 - NHF vs NIV in Patients With Acute Exacerbation of COPD N/A